SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-17-001245
Filing Date
2017-03-03
Accepted
2017-03-03 16:39:42
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 a2231127zs-3.htm S-3 313834
2 EX-1.2 a2231127zex-1_2.htm EX-1.2 232254
3 EX-4.7 a2231127zex-4_7.htm EX-4.7 461782
4 EX-4.8 a2231127zex-4_8.htm EX-4.8 456238
5 EX-5.1 a2231127zex-5_1.htm EX-5.1 36699
6 EX-5.2 a2231127zex-5_2.htm EX-5.2 12655
7 EX-12.1 a2231127zex-12_1.htm EX-12.1 21781
8 EX-23.1 a2231127zex-23_1.htm EX-23.1 3233
9 G579169.JPG g579169.jpg GRAPHIC 14131
10 G73762KMI001.GIF g73762kmi001.gif GRAPHIC 4455
11 G73762KOI001.JPG g73762koi001.jpg GRAPHIC 3144
  Complete submission text file 0001047469-17-001245.txt   1569764
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-216438 | Film No.: 17664327
SIC: 2834 Pharmaceutical Preparations